Knoll Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Knoll Capital Management, LLC holds 6 biotech & pharma companies tracked by BioSniper, totaling $30.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$30.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Aldeyra Therapeutics, Inc. (ALDX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALDXAldeyra Therapeutics, Inc. | 5,475,516 | $9.3M |
| ELTXElicio Therapeutics, Inc. | 630,915 | $6.7M |
| NUVBNuvation Bio Inc. | 1,498,591 | $6.4M |
| OCULOCULAR THERAPEUTIX, INC | 600,400 | $5.1M |
| ABEOABEONA THERAPEUTICS INC. | 485,515 | $2.2M |
| ALTAltimmune, Inc. | 160,000 | $493K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.